JOURNEY AS AN ORTHOPAEDIC SURGEON, RESEARCHER, SURGICAL SITE INFECTION CONTROL & BONE LOSS EXPERT Associate Professor Kevin Tetsworth, Orthopaedic Surgeon
As an orthopaedic surgeon, Associate Professor Kevin Tetsworth, is widely recognised for his expertise in managing orthopaedic infections, chronic osteomyelitis, limb salvage, and reconstruction. He holds clinical appointments at the Royal Brisbane and Women’s Hospital, the Wesley Hospital in Brisbane, Macquarie University in Sydney at the Limb Reconstruction Centre.
His credentials encompass a fellowship in the American Academy, a fellowship in the Royal College in Australia, and membership in the Australian Orthopaedic Association and the International Orthopaedic Trauma Association. Associate Professor Tetsworth’s clinical focus revolves around the comprehensive management of orthopaedic infections, segmental bone defects, high-energy trauma, limb salvage and reconstruction, deformity correction, limb lengthening, and prosthetic joint infections.
In tandem with his clinical practice, Associate Professor Tetsworth is deeply engaged in orthopaedic research, with a keen interest in infection management, infection control, limb salvage, bone defect reconstruction, biomarker development for infection, bone growth hormone delivery, and the use of 3D printed models for reconstructing segmental bone defects.
His professional journey has been profoundly shaped by training under esteemed mentors like Professor Dror Paley and Dr George Cierny in the United States. This formative training has equipped him with a high level of expertise in addressing complex orthopaedic conditions, particularly those related to bone loss and infection. Having practiced in the United States, notably at the University of Maryland and the shock trauma hospital in Baltimore, Associate Professor Tetsworth relocated to Australia in 2000 and has since played a pivotal role in advancing orthopaedic surgery at the Royal Brisbane Hospital.
Associate Professor Tetsworth’s unwavering commitment to advancing orthopaedic knowledge and his exceptional proficiency in managing challenging orthopaedic conditions have earned him widespread recognition within the field.
In this Australian Health Journal interview, Assoc Professor Tetsworth talks about his clinical and research career journey and gives advice for those in medicine considering a career in orthopaedic surgery,
Assoc Prof Tetsworth concludes with a discussion on ways infection control is handled in preoperative, intraoperative and post operatively for orthopaedic surgeries.
He discusses the techniques started in the 19th century with understanding of hand hygiene, surgical instruments being sterilised and discovery of antibiotics in the 20th century, to present day practises of patient modifiable factors such as prescreening patients, lifestyle adjustments such as BMI or weight management, checking HbA1c levels for those who are diabetic and use of triclosan coated sutures in wound dressing in the early post operative period.
-
Thyroid health into pregnancy
‘Without an adequate amount of thyroid hormone mothers can be exposed to hypertensive disorders of pregnancy, including gestational hypertension and preeclampsia or eclampsia, which affect around 10% of pregnant women and are the leading causes of maternal and neonatal mortality worldwide. Mothers who suffer from hypertensive disorders during pregnancy are at increased risk of long-term cardiovascular consequences and hypertensive disorders in subsequent pregnancies. Evidence also indicates a risk of reduced cognitive ability to their offspring.
‘Knowing if you are genetically predisposed to Hashimoto’s or Graves’ Diseases, which are both thyroid autoimmune disorders is important to be aware of, to ensure all appropriate tests are ordered. Autoimmune disorders may predispose mothers to a thyroid problem during pregnancy’, says Professor Creswell Eastman, who also serves as the ATF’s Principal Medical Advisor.
-
Medicinal cannabis in Australia Update
According to the Australian Journal of General Practice, published by the Royal Australian College of General Practitioners, more than 130,000 medicinal cannabis approvals have been issued in Australia to date, mostly by general practitioners, with approximately 65% of these to treat chronic non-cancer pain. Despite robust supportive data from animal models, current clinical trial evidence for THC and CBD efficacy in chronic pain is incomplete. In their prescribing decisions, doctors must balance patient demand and curiosity with caution regarding potential risks and limited efficacy (Source: https://www1.racgp.org.au/ajgp/2021/october/medicinal-cannabis)
Australian Health Journal met with 3 speakers at the recent @arcsaustralia ARCS22 Conference providing an update on medicinal cannabis. The discussion with the speakers now centres on affordability and access.
-
Keeping elderly out of hospital
Pioneer in health care, Geriatrician Professor Susan Kurrle, Curran Professor in Health Care of Older People at the Faculty of Medicine and Health, University of Sydney AO spoke after receiving the Australian Healthcare and Hospitals Association 2022 Sidney Sax medal award.
The Sidney Sax medal is awarded for outstanding contributions to the development and improvement of Australia’s healthcare system.
